TrialLancet (London, England)2016

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.

William D Tap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.